May 31, 2017 13:06 pm UTC| Business
EAGAN, Minn., May 31, 2017 -- Biothera Pharmaceuticals, Inc. announced today that a poster about the design of IMPRIME-1™, the company’s ongoing Phase 2 clinical trial in advanced melanoma/triple negative breast cancer,...
May 31, 2017 13:06 pm UTC| Business
EAGAN, Minn., May 31, 2017 -- Biothera Pharmaceuticals, Inc. announced today that a poster about the design of IMPRIME-1™, the company’s ongoing Phase 2 clinical trial in advanced melanoma/triple negative breast cancer,...
May 31, 2017 13:06 pm UTC| Business
EAGAN, Minn., May 31, 2017 -- Biothera Pharmaceuticals, Inc. announced today that a poster about the design of IMPRIME-1™, the company’s ongoing Phase 2 clinical trial in advanced melanoma/triple negative breast cancer,...
May 31, 2017 13:06 pm UTC| Business
EAGAN, Minn., May 31, 2017 -- Biothera Pharmaceuticals, Inc. announced today that a poster about the design of IMPRIME-1™, the company’s ongoing Phase 2 clinical trial in advanced melanoma/triple negative breast cancer,...
Cytori and BARDA Execute $13.4 Million Contract Option for Burn Clinical Trial
May 31, 2017 13:05 pm UTC| Business
SAN DIEGO, May 31, 2017 -- Cytori Therapeutics, Inc.(NASDAQ:CYTX) (“Cytori” or the “Company”) today announced that the Company andthe Biomedical Advanced Researchand Development Authority (BARDA), a division of theU.S....
Cytori and BARDA Execute $13.4 Million Contract Option for Burn Clinical Trial
May 31, 2017 13:05 pm UTC| Business
SAN DIEGO, May 31, 2017 -- Cytori Therapeutics, Inc.(NASDAQ:CYTX) (“Cytori” or the “Company”) today announced that the Company andthe Biomedical Advanced Researchand Development Authority (BARDA), a division of theU.S....
Cytori and BARDA Execute $13.4 Million Contract Option for Burn Clinical Trial
May 31, 2017 13:05 pm UTC| Business
SAN DIEGO, May 31, 2017 -- Cytori Therapeutics, Inc.(NASDAQ:CYTX) (“Cytori” or the “Company”) today announced that the Company andthe Biomedical Advanced Researchand Development Authority (BARDA), a division of theU.S....
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave